ISMBE 2019 | Biomedical engineering conference in Haifa, Israel.
  • About
    • Conference Photos
    • Welcome Letter
    • General Information
    • Who should Attend?
  • Program
    • Our Speakers
    • Startup Challenge
    • Conference Program
    • Program at a Glance
    • Previous Conferences
    • Committees
    • Abstract submission
    • Topics
  • Sponsorship & Exhibition
    • Sponsorship Opportunities
    • Sponsors & Exhibitors List
  • About Israel
    • Discover Israel
  • Registration
    • Registration for Israelis
    • Registration for Non Israelis
    • Accommodation
  • About
    • Conference Photos
    • Welcome Letter
    • General Information
    • Who should Attend?
  • Program
    • Our Speakers
    • Startup Challenge
    • Conference Program
    • Program at a Glance
    • Previous Conferences
    • Committees
    • Abstract submission
    • Topics
  • Sponsorship & Exhibition
    • Sponsorship Opportunities
    • Sponsors & Exhibitors List
  • About Israel
    • Discover Israel
  • Registration
    • Registration for Israelis
    • Registration for Non Israelis
    • Accommodation
David Israeli
Home » David Israeli

David Israeli

Dr. David Israeli is the Chairman & CEO of Magenta Medical, a start-up company developing innovative therapies for the treatment of acute decompensated heart failure. Immediately prior to this, David was the Chief Medical Officer of Ossio Ltd., a start-company developing novel implants for orthopedic fixation.
Previously, he was a life sciences General Partner at Pitango Venture Capital, one of the leading VC groups in Israel, where he led investments in the areas of medical devices and digital health.
Before joining Pitango, David was the Director of Business Development and Marketing at Medtronic Ventor Technologies, following Medtronic’s acquisition of Ventor Technologies in early 2009.
Prior to this, David spent several years in the United States. After earning an MBA, he joined Medtronic and filled roles ranging from corporate development and M&A to business and market development. David then went on to become the VP of Medical Affairs at Rhythmia Medical, which was acquired by Boston Scientific in October 2012. David holds an MD from the Hebrew University of Jerusalem and an MBA from the Harvard Business School.

Registration
Abstract submission

Registration
Abstract submission

KEEP ME UPDATED

Logo paragon
Paragon Israel (Dan Knassim)
Tel:+972-3-5767715
Email: nkappon@paragong.com
©All Rights reserved
Privacy policy | Sitemap
Created By web3d.co.il
Scroll to top